Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 40 | 2023 | 765 | 7.100 |
Why?
|
Cognition Disorders | 28 | 2016 | 551 | 3.440 |
Why?
|
Brain Injuries, Traumatic | 13 | 2024 | 381 | 3.040 |
Why?
|
Neuropsychological Tests | 32 | 2024 | 918 | 2.210 |
Why?
|
Memory Disorders | 8 | 2024 | 236 | 2.140 |
Why?
|
Neuropsychiatry | 6 | 2020 | 12 | 2.030 |
Why?
|
Bipolar Disorder | 11 | 2023 | 306 | 1.980 |
Why?
|
Cholinesterase Inhibitors | 5 | 2024 | 100 | 1.700 |
Why?
|
Mental Disorders | 18 | 2014 | 819 | 1.520 |
Why?
|
Neurosciences | 3 | 2017 | 50 | 1.470 |
Why?
|
Indans | 2 | 2024 | 55 | 1.310 |
Why?
|
Piperidines | 2 | 2024 | 204 | 1.200 |
Why?
|
Depressive Disorder, Major | 6 | 2023 | 388 | 1.120 |
Why?
|
Crying | 6 | 2014 | 12 | 1.110 |
Why?
|
Mood Disorders | 6 | 2023 | 122 | 1.060 |
Why?
|
Brain | 21 | 2023 | 2980 | 1.050 |
Why?
|
Consciousness Disorders | 5 | 2023 | 23 | 1.040 |
Why?
|
Affective Symptoms | 5 | 2014 | 58 | 1.000 |
Why?
|
Psychotic Disorders | 5 | 2015 | 135 | 0.950 |
Why?
|
Frontotemporal Dementia | 2 | 2023 | 43 | 0.950 |
Why?
|
Nootropic Agents | 1 | 2024 | 27 | 0.940 |
Why?
|
Laughter | 5 | 2014 | 10 | 0.920 |
Why?
|
Aggression | 4 | 2014 | 220 | 0.900 |
Why?
|
Alcoholism | 6 | 2022 | 232 | 0.860 |
Why?
|
Consciousness | 1 | 2023 | 49 | 0.850 |
Why?
|
Hypoxia-Ischemia, Brain | 3 | 2010 | 80 | 0.840 |
Why?
|
Humans | 125 | 2024 | 124161 | 0.830 |
Why?
|
Receptors, Cholinergic | 4 | 2011 | 84 | 0.800 |
Why?
|
Evoked Potentials, Auditory | 6 | 2004 | 53 | 0.790 |
Why?
|
Lupus Erythematosus, Systemic | 8 | 2013 | 188 | 0.780 |
Why?
|
Nervous System Diseases | 7 | 2020 | 374 | 0.770 |
Why?
|
Memory | 7 | 2024 | 362 | 0.750 |
Why?
|
Forensic Psychiatry | 2 | 2013 | 12 | 0.730 |
Why?
|
Psychomotor Performance | 5 | 2011 | 181 | 0.710 |
Why?
|
Psychiatry | 4 | 2016 | 262 | 0.690 |
Why?
|
Irritable Mood | 3 | 2022 | 8 | 0.690 |
Why?
|
Functional Laterality | 8 | 2016 | 182 | 0.680 |
Why?
|
Cognition | 7 | 2018 | 707 | 0.680 |
Why?
|
Brain Concussion | 5 | 2023 | 229 | 0.670 |
Why?
|
Adult | 50 | 2024 | 29340 | 0.660 |
Why?
|
Acetylcholine | 4 | 2011 | 84 | 0.630 |
Why?
|
Hippocampus | 9 | 2019 | 821 | 0.630 |
Why?
|
Hallucinations | 2 | 2016 | 26 | 0.620 |
Why?
|
Amnesia | 3 | 2023 | 19 | 0.620 |
Why?
|
Attention | 9 | 2019 | 187 | 0.600 |
Why?
|
Brain Injury, Chronic | 2 | 2013 | 21 | 0.600 |
Why?
|
Autism Spectrum Disorder | 1 | 2023 | 384 | 0.600 |
Why?
|
Antipsychotic Agents | 4 | 2015 | 361 | 0.590 |
Why?
|
Confusion | 2 | 2020 | 16 | 0.590 |
Why?
|
Diagnosis, Differential | 16 | 2017 | 1878 | 0.580 |
Why?
|
Cholinergic Fibers | 3 | 2011 | 9 | 0.580 |
Why?
|
Aphasia | 2 | 2015 | 13 | 0.570 |
Why?
|
Neurology | 2 | 2010 | 107 | 0.530 |
Why?
|
Male | 64 | 2024 | 60995 | 0.520 |
Why?
|
Politics | 1 | 2017 | 58 | 0.520 |
Why?
|
Severity of Illness Index | 12 | 2011 | 2882 | 0.520 |
Why?
|
Capgras Syndrome | 1 | 2016 | 3 | 0.510 |
Why?
|
Impulsive Behavior | 2 | 2014 | 143 | 0.510 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2014 | 202 | 0.510 |
Why?
|
Diffusion Tensor Imaging | 2 | 2024 | 234 | 0.510 |
Why?
|
Expert Testimony | 2 | 2013 | 37 | 0.500 |
Why?
|
Middle Aged | 39 | 2024 | 26589 | 0.490 |
Why?
|
Recovery of Function | 5 | 2019 | 440 | 0.490 |
Why?
|
Dopamine Agents | 2 | 2006 | 28 | 0.490 |
Why?
|
Dementia | 3 | 2013 | 445 | 0.490 |
Why?
|
Pseudobulbar Palsy | 2 | 2005 | 4 | 0.490 |
Why?
|
Stroke Rehabilitation | 2 | 2005 | 52 | 0.480 |
Why?
|
Journalism, Medical | 1 | 2015 | 9 | 0.470 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2015 | 44 | 0.460 |
Why?
|
Double-Blind Method | 6 | 2024 | 1629 | 0.450 |
Why?
|
Connectome | 3 | 2023 | 95 | 0.450 |
Why?
|
West Nile Fever | 2 | 2008 | 139 | 0.450 |
Why?
|
Football | 1 | 2013 | 31 | 0.420 |
Why?
|
Schizophrenia | 4 | 2015 | 300 | 0.410 |
Why?
|
Periodicals as Topic | 1 | 2016 | 197 | 0.410 |
Why?
|
Mental Status Schedule | 2 | 2010 | 44 | 0.410 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 120 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 19 | 2023 | 3547 | 0.410 |
Why?
|
Behavioral Symptoms | 1 | 2013 | 25 | 0.410 |
Why?
|
Surveys and Questionnaires | 5 | 2023 | 3683 | 0.400 |
Why?
|
Neurotransmitter Agents | 3 | 2008 | 146 | 0.400 |
Why?
|
Violence | 1 | 2013 | 116 | 0.390 |
Why?
|
Post-Concussion Syndrome | 3 | 2013 | 54 | 0.380 |
Why?
|
Phenylcarbamates | 2 | 2009 | 15 | 0.380 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2015 | 801 | 0.380 |
Why?
|
Female | 48 | 2024 | 66270 | 0.370 |
Why?
|
Veterans | 4 | 2023 | 1752 | 0.370 |
Why?
|
Electroencephalography | 4 | 2015 | 863 | 0.350 |
Why?
|
Indians, North American | 2 | 2010 | 59 | 0.350 |
Why?
|
Treatment Outcome | 14 | 2024 | 12289 | 0.350 |
Why?
|
Suicide | 1 | 2013 | 169 | 0.350 |
Why?
|
Military Personnel | 2 | 2023 | 212 | 0.350 |
Why?
|
Delirium | 2 | 2024 | 55 | 0.340 |
Why?
|
Capital Punishment | 1 | 2010 | 3 | 0.340 |
Why?
|
Neuroprotective Agents | 2 | 2009 | 157 | 0.340 |
Why?
|
Cerebral Cortex | 5 | 2019 | 451 | 0.330 |
Why?
|
Public Policy | 1 | 2010 | 51 | 0.330 |
Why?
|
Cognitive Dysfunction | 2 | 2024 | 227 | 0.320 |
Why?
|
Geriatric Assessment | 1 | 2010 | 142 | 0.320 |
Why?
|
Injury Severity Score | 5 | 2019 | 227 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 106 | 0.310 |
Why?
|
Amygdala | 3 | 2018 | 74 | 0.310 |
Why?
|
Reflex | 1 | 2009 | 51 | 0.310 |
Why?
|
Affect | 4 | 2008 | 153 | 0.300 |
Why?
|
Central Nervous System Stimulants | 4 | 2016 | 126 | 0.300 |
Why?
|
Physical Therapy Modalities | 2 | 2005 | 50 | 0.300 |
Why?
|
Insanity Defense | 1 | 2008 | 3 | 0.300 |
Why?
|
Neuroanatomy | 2 | 2023 | 11 | 0.290 |
Why?
|
White Matter | 2 | 2024 | 178 | 0.290 |
Why?
|
Depression | 4 | 2009 | 1213 | 0.290 |
Why?
|
Crime | 1 | 2008 | 26 | 0.290 |
Why?
|
Stroke | 5 | 2015 | 974 | 0.290 |
Why?
|
Dibenzothiazepines | 1 | 2007 | 14 | 0.290 |
Why?
|
Aged | 16 | 2024 | 19533 | 0.280 |
Why?
|
Rivastigmine | 3 | 2021 | 17 | 0.280 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 429 | 0.270 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 1085 | 0.260 |
Why?
|
Hiccup | 1 | 2006 | 6 | 0.260 |
Why?
|
Adrenergic Agents | 1 | 2006 | 12 | 0.260 |
Why?
|
Methylphenidate | 3 | 2016 | 57 | 0.260 |
Why?
|
Alzheimer Disease | 3 | 2011 | 798 | 0.260 |
Why?
|
Behavioral Sciences | 1 | 2006 | 8 | 0.260 |
Why?
|
Neuropsychology | 1 | 2006 | 23 | 0.250 |
Why?
|
Hemiplegia | 1 | 2005 | 44 | 0.250 |
Why?
|
Motor Skills | 1 | 2005 | 77 | 0.240 |
Why?
|
Paresis | 1 | 2005 | 35 | 0.240 |
Why?
|
Specialization | 1 | 2006 | 74 | 0.240 |
Why?
|
Upper Extremity | 1 | 2005 | 49 | 0.240 |
Why?
|
Amantadine | 1 | 2004 | 10 | 0.240 |
Why?
|
Disability Evaluation | 3 | 2019 | 188 | 0.240 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2021 | 629 | 0.240 |
Why?
|
Research Design | 1 | 2009 | 687 | 0.230 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2004 | 9 | 0.230 |
Why?
|
Neurologic Examination | 5 | 2008 | 194 | 0.230 |
Why?
|
Psychosurgery | 1 | 2004 | 27 | 0.230 |
Why?
|
Healthy Aging | 1 | 2024 | 7 | 0.230 |
Why?
|
Exercise Therapy | 1 | 2005 | 134 | 0.220 |
Why?
|
Mental Competency | 1 | 2024 | 51 | 0.220 |
Why?
|
Emotions | 3 | 2019 | 349 | 0.220 |
Why?
|
Comorbidity | 3 | 2014 | 1529 | 0.220 |
Why?
|
Neuroimaging | 5 | 2019 | 333 | 0.210 |
Why?
|
Myelin Sheath | 1 | 2024 | 121 | 0.210 |
Why?
|
Hospital Mortality | 1 | 2008 | 1022 | 0.210 |
Why?
|
Analysis of Variance | 5 | 2007 | 1008 | 0.210 |
Why?
|
Critical Care | 1 | 2008 | 656 | 0.210 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 453 | 0.200 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 2142 | 0.200 |
Why?
|
Magnetoencephalography | 5 | 2011 | 33 | 0.200 |
Why?
|
Valproic Acid | 2 | 2022 | 162 | 0.200 |
Why?
|
Delusions | 2 | 2015 | 17 | 0.200 |
Why?
|
Young Adult | 7 | 2024 | 8988 | 0.190 |
Why?
|
Regression Analysis | 5 | 2013 | 776 | 0.190 |
Why?
|
Thalamus | 2 | 2018 | 82 | 0.190 |
Why?
|
Prisoners | 1 | 2021 | 35 | 0.190 |
Why?
|
Dominance, Cerebral | 1 | 2000 | 55 | 0.180 |
Why?
|
Central Nervous System Agents | 1 | 2000 | 14 | 0.180 |
Why?
|
Mental Status and Dementia Tests | 1 | 2020 | 16 | 0.170 |
Why?
|
Suicidal Ideation | 2 | 2023 | 211 | 0.170 |
Why?
|
Rehabilitation Centers | 1 | 2020 | 33 | 0.170 |
Why?
|
Hospitalization | 1 | 2008 | 1769 | 0.170 |
Why?
|
Conversion Disorder | 1 | 2020 | 9 | 0.170 |
Why?
|
Physical and Rehabilitation Medicine | 1 | 2020 | 28 | 0.160 |
Why?
|
Prospective Studies | 6 | 2017 | 6117 | 0.160 |
Why?
|
Electroconvulsive Therapy | 2 | 2014 | 67 | 0.160 |
Why?
|
Chronic Traumatic Encephalopathy | 1 | 2019 | 6 | 0.160 |
Why?
|
Acceptance and Commitment Therapy | 1 | 2020 | 41 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2013 | 288 | 0.160 |
Why?
|
Glasgow Coma Scale | 2 | 2011 | 208 | 0.160 |
Why?
|
Adult Survivors of Child Adverse Events | 1 | 2019 | 14 | 0.160 |
Why?
|
Facial Expression | 1 | 2019 | 27 | 0.160 |
Why?
|
Biomechanical Phenomena | 2 | 2011 | 225 | 0.160 |
Why?
|
Sensory Thresholds | 1 | 1999 | 34 | 0.160 |
Why?
|
Lithium Compounds | 1 | 2018 | 10 | 0.150 |
Why?
|
Habenula | 1 | 2018 | 43 | 0.150 |
Why?
|
Brain Diseases | 1 | 2000 | 298 | 0.140 |
Why?
|
Spatial Memory | 1 | 2017 | 37 | 0.140 |
Why?
|
Glutamic Acid | 2 | 2011 | 201 | 0.140 |
Why?
|
Sertraline | 2 | 2009 | 44 | 0.140 |
Why?
|
Choline | 4 | 2013 | 54 | 0.140 |
Why?
|
Aged, 80 and over | 4 | 2011 | 6465 | 0.140 |
Why?
|
Suicide, Attempted | 1 | 2018 | 128 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2019 | 2862 | 0.140 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 237 | 0.130 |
Why?
|
Encephalitis | 1 | 2017 | 109 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 632 | 0.130 |
Why?
|
Aspartic Acid | 3 | 2011 | 73 | 0.120 |
Why?
|
Range of Motion, Articular | 2 | 2005 | 67 | 0.120 |
Why?
|
Prognosis | 4 | 2019 | 4608 | 0.120 |
Why?
|
Frontal Lobe | 3 | 2013 | 116 | 0.120 |
Why?
|
Behavior, Animal | 1 | 2017 | 493 | 0.120 |
Why?
|
Case-Control Studies | 5 | 2011 | 3266 | 0.110 |
Why?
|
Anxiety Disorders | 2 | 2014 | 673 | 0.110 |
Why?
|
Executive Function | 2 | 2016 | 110 | 0.110 |
Why?
|
Creatine | 2 | 2011 | 41 | 0.110 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 142 | 0.110 |
Why?
|
Length of Stay | 2 | 2011 | 1303 | 0.110 |
Why?
|
Terminology as Topic | 2 | 2008 | 222 | 0.110 |
Why?
|
Volition | 2 | 2006 | 11 | 0.110 |
Why?
|
Referral and Consultation | 3 | 2024 | 542 | 0.100 |
Why?
|
Leukoencephalopathies | 1 | 2013 | 59 | 0.100 |
Why?
|
Multiple Sclerosis | 2 | 2007 | 329 | 0.100 |
Why?
|
Hyperbaric Oxygenation | 1 | 2012 | 20 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2019 | 16280 | 0.100 |
Why?
|
United States | 6 | 2023 | 10861 | 0.100 |
Why?
|
Blast Injuries | 1 | 2012 | 58 | 0.100 |
Why?
|
Inpatients | 2 | 2018 | 492 | 0.100 |
Why?
|
Cohort Studies | 4 | 2023 | 4780 | 0.090 |
Why?
|
Anxiety | 1 | 2017 | 941 | 0.090 |
Why?
|
Forensic Medicine | 1 | 2011 | 12 | 0.090 |
Why?
|
Neurobiology | 1 | 2011 | 25 | 0.090 |
Why?
|
Rest | 1 | 2011 | 57 | 0.090 |
Why?
|
Trauma Severity Indices | 1 | 2011 | 88 | 0.090 |
Why?
|
Risk Assessment | 3 | 2011 | 3430 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2014 | 436 | 0.090 |
Why?
|
Delphi Technique | 2 | 2023 | 211 | 0.090 |
Why?
|
Schizophrenic Psychology | 2 | 2002 | 82 | 0.090 |
Why?
|
Economics | 1 | 2010 | 12 | 0.080 |
Why?
|
Language Disorders | 1 | 2010 | 24 | 0.080 |
Why?
|
Supreme Court Decisions | 1 | 2010 | 14 | 0.080 |
Why?
|
Antidepressive Agents | 2 | 2018 | 284 | 0.080 |
Why?
|
Adolescent | 6 | 2019 | 19240 | 0.080 |
Why?
|
Animals | 7 | 2017 | 34040 | 0.080 |
Why?
|
Phenotype | 1 | 1999 | 4249 | 0.080 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 1999 | 47 | 0.080 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2009 | 25 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 2089 | 0.080 |
Why?
|
Citalopram | 1 | 2009 | 30 | 0.080 |
Why?
|
Capsules | 1 | 2009 | 21 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2010 | 209 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2010 | 90 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 149 | 0.080 |
Why?
|
Research | 1 | 2011 | 263 | 0.080 |
Why?
|
Atrophy | 2 | 2007 | 228 | 0.080 |
Why?
|
Time | 1 | 2009 | 93 | 0.080 |
Why?
|
Autoantibodies | 1 | 2011 | 434 | 0.080 |
Why?
|
Antibodies | 1 | 2010 | 372 | 0.080 |
Why?
|
Motor Activity | 2 | 2017 | 509 | 0.080 |
Why?
|
Consensus | 2 | 2023 | 638 | 0.080 |
Why?
|
Neurochemistry | 1 | 2008 | 5 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2010 | 147 | 0.070 |
Why?
|
Medical Records | 1 | 2009 | 189 | 0.070 |
Why?
|
Dissociative Disorders | 1 | 2008 | 10 | 0.070 |
Why?
|
Quetiapine Fumarate | 1 | 2007 | 16 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 2445 | 0.070 |
Why?
|
Presenilin-2 | 1 | 2007 | 18 | 0.070 |
Why?
|
Sex Factors | 2 | 2003 | 1277 | 0.070 |
Why?
|
Presenilin-1 | 1 | 2007 | 53 | 0.070 |
Why?
|
Wasting Disease, Chronic | 1 | 2007 | 1 | 0.070 |
Why?
|
Receptors, Neurotransmitter | 1 | 2007 | 21 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 722 | 0.070 |
Why?
|
Disease Progression | 2 | 2011 | 2043 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2023 | 1319 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2007 | 108 | 0.070 |
Why?
|
Neurosecretory Systems | 1 | 2007 | 23 | 0.070 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2006 | 7 | 0.070 |
Why?
|
Intelligence Tests | 1 | 2007 | 57 | 0.070 |
Why?
|
Disease Management | 1 | 2010 | 518 | 0.070 |
Why?
|
Expressed Emotion | 1 | 2006 | 9 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 2041 | 0.060 |
Why?
|
Lithium Carbonate | 1 | 2006 | 19 | 0.060 |
Why?
|
Biogenic Amines | 1 | 2006 | 19 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 2806 | 0.060 |
Why?
|
Incidence | 2 | 2011 | 3135 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2006 | 217 | 0.060 |
Why?
|
Illusions | 1 | 2006 | 8 | 0.060 |
Why?
|
Demography | 1 | 2007 | 239 | 0.060 |
Why?
|
Cytokines | 1 | 2011 | 1289 | 0.060 |
Why?
|
Health Surveys | 1 | 2007 | 241 | 0.060 |
Why?
|
Medical History Taking | 1 | 2006 | 108 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2006 | 98 | 0.060 |
Why?
|
Gyrus Cinguli | 2 | 2023 | 114 | 0.060 |
Why?
|
Education | 1 | 2006 | 109 | 0.060 |
Why?
|
Restraint, Physical | 1 | 2005 | 24 | 0.060 |
Why?
|
Patient Selection | 1 | 2009 | 689 | 0.060 |
Why?
|
Diazepam | 1 | 2004 | 21 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2005 | 284 | 0.060 |
Why?
|
Probability | 1 | 2005 | 322 | 0.060 |
Why?
|
Psychological Tests | 1 | 2005 | 90 | 0.060 |
Why?
|
Arm | 1 | 2005 | 81 | 0.060 |
Why?
|
History, Ancient | 1 | 2004 | 53 | 0.060 |
Why?
|
Cooperative Behavior | 2 | 2006 | 218 | 0.060 |
Why?
|
Narcotics | 1 | 2004 | 63 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2004 | 64 | 0.060 |
Why?
|
Cognitive Aging | 1 | 2024 | 2 | 0.060 |
Why?
|
Inflammation | 1 | 2011 | 1428 | 0.060 |
Why?
|
Colorado | 3 | 2011 | 22 | 0.060 |
Why?
|
Nerve Net | 1 | 2007 | 239 | 0.060 |
Why?
|
History, 19th Century | 1 | 2004 | 116 | 0.060 |
Why?
|
Physostigmine | 1 | 2004 | 9 | 0.060 |
Why?
|
Age of Onset | 1 | 2006 | 585 | 0.060 |
Why?
|
Time Factors | 2 | 2007 | 6283 | 0.060 |
Why?
|
Methadone | 1 | 2004 | 126 | 0.060 |
Why?
|
North America | 1 | 2004 | 239 | 0.060 |
Why?
|
Corpus Callosum | 1 | 2024 | 94 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2005 | 372 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2004 | 136 | 0.050 |
Why?
|
Akinetic Mutism | 1 | 2003 | 1 | 0.050 |
Why?
|
Chronic Disease | 2 | 2005 | 1179 | 0.050 |
Why?
|
Datasets as Topic | 1 | 2023 | 89 | 0.050 |
Why?
|
Cerebral Arterial Diseases | 1 | 2003 | 5 | 0.050 |
Why?
|
Electrophysiology | 1 | 2003 | 271 | 0.050 |
Why?
|
Physician's Role | 1 | 2004 | 164 | 0.050 |
Why?
|
History, 20th Century | 1 | 2004 | 382 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2006 | 279 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2002 | 29 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2005 | 385 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2005 | 450 | 0.050 |
Why?
|
Geriatric Psychiatry | 1 | 2002 | 11 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2005 | 375 | 0.050 |
Why?
|
Health Services for the Aged | 1 | 2002 | 36 | 0.050 |
Why?
|
Prefrontal Cortex | 1 | 2023 | 184 | 0.050 |
Why?
|
Unconsciousness | 1 | 2001 | 17 | 0.050 |
Why?
|
Acute Disease | 1 | 2004 | 1107 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2021 | 8 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2005 | 332 | 0.040 |
Why?
|
Psychotherapy | 1 | 2003 | 229 | 0.040 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2000 | 4 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2011 | 4343 | 0.040 |
Why?
|
Psychomotor Disorders | 1 | 2000 | 28 | 0.040 |
Why?
|
Societies, Medical | 2 | 2020 | 686 | 0.040 |
Why?
|
Curriculum | 1 | 2006 | 726 | 0.040 |
Why?
|
Rehabilitation Research | 1 | 2020 | 1 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2000 | 90 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 509 | 0.040 |
Why?
|
Patient Discharge | 1 | 2024 | 486 | 0.040 |
Why?
|
Epilepsies, Partial | 1 | 2000 | 91 | 0.040 |
Why?
|
Treatment Failure | 1 | 2021 | 338 | 0.040 |
Why?
|
Social Stigma | 1 | 2020 | 69 | 0.040 |
Why?
|
Magnetics | 1 | 1999 | 40 | 0.040 |
Why?
|
Happiness | 1 | 2019 | 9 | 0.040 |
Why?
|
Pituitary Gland | 1 | 1999 | 82 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2020 | 91 | 0.040 |
Why?
|
Mass Screening | 1 | 2005 | 781 | 0.040 |
Why?
|
Reaction Time | 1 | 2000 | 170 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2000 | 123 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2019 | 47 | 0.040 |
Why?
|
Decision Making | 1 | 2024 | 653 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 1228 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2019 | 144 | 0.040 |
Why?
|
Temporal Lobe | 1 | 2019 | 111 | 0.040 |
Why?
|
Reference Values | 1 | 2000 | 711 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 5129 | 0.040 |
Why?
|
Organ Size | 1 | 2019 | 426 | 0.040 |
Why?
|
Gray Matter | 1 | 2018 | 27 | 0.040 |
Why?
|
Gliosis | 1 | 2017 | 29 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2019 | 283 | 0.040 |
Why?
|
Fear | 1 | 2019 | 193 | 0.040 |
Why?
|
Syndrome | 1 | 2000 | 1119 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1999 | 218 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2004 | 769 | 0.030 |
Why?
|
Maze Learning | 1 | 2017 | 128 | 0.030 |
Why?
|
Aging | 1 | 2024 | 1165 | 0.030 |
Why?
|
Brain Chemistry | 2 | 2009 | 124 | 0.030 |
Why?
|
Microglia | 1 | 2017 | 97 | 0.030 |
Why?
|
Biomarkers | 2 | 2011 | 3049 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2010 | 307 | 0.030 |
Why?
|
Models, Animal | 1 | 2017 | 460 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2015 | 107 | 0.030 |
Why?
|
Astrocytes | 1 | 2017 | 248 | 0.030 |
Why?
|
Linear Models | 1 | 2016 | 667 | 0.030 |
Why?
|
Caregivers | 1 | 2020 | 555 | 0.030 |
Why?
|
Software | 1 | 1999 | 677 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2011 | 1421 | 0.030 |
Why?
|
Recurrence | 1 | 2017 | 1421 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 297 | 0.030 |
Why?
|
Pilot Projects | 2 | 2010 | 1370 | 0.030 |
Why?
|
Child | 2 | 2019 | 24349 | 0.030 |
Why?
|
Risk Factors | 2 | 2004 | 10245 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2013 | 140 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2004 | 3063 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 389 | 0.020 |
Why?
|
Visual Perception | 1 | 2011 | 121 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 585 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 3415 | 0.020 |
Why?
|
Brain Mapping | 1 | 2011 | 396 | 0.020 |
Why?
|
Neurofibrillary Tangles | 1 | 2007 | 26 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2007 | 39 | 0.020 |
Why?
|
Mental Health Services | 1 | 2010 | 256 | 0.020 |
Why?
|
Pituitary Hormones, Anterior | 1 | 2007 | 3 | 0.020 |
Why?
|
Disease Reservoirs | 1 | 2007 | 35 | 0.020 |
Why?
|
Pituitary Gland, Anterior | 1 | 2007 | 21 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2007 | 140 | 0.020 |
Why?
|
Thyrotropin | 1 | 2007 | 57 | 0.020 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2007 | 14 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2007 | 75 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2007 | 54 | 0.020 |
Why?
|
Prolactin | 1 | 2007 | 114 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2007 | 355 | 0.020 |
Why?
|
Introns | 1 | 2007 | 299 | 0.020 |
Why?
|
Antiemetics | 1 | 2006 | 22 | 0.020 |
Why?
|
Stereotyping | 1 | 2006 | 19 | 0.020 |
Why?
|
Point Mutation | 1 | 2007 | 346 | 0.020 |
Why?
|
Benzamides | 1 | 2006 | 105 | 0.020 |
Why?
|
Saliva | 1 | 2006 | 114 | 0.020 |
Why?
|
Axons | 1 | 2009 | 377 | 0.020 |
Why?
|
Vomiting | 1 | 2006 | 106 | 0.020 |
Why?
|
Mental Processes | 1 | 2005 | 40 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2005 | 47 | 0.020 |
Why?
|
Carbamazepine | 1 | 2005 | 48 | 0.020 |
Why?
|
Skull | 1 | 2006 | 142 | 0.020 |
Why?
|
MEDLINE | 1 | 2005 | 20 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 2005 | 106 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 811 | 0.010 |
Why?
|
Pain | 1 | 2007 | 447 | 0.010 |
Why?
|
Language | 1 | 2005 | 200 | 0.010 |
Why?
|
Central Nervous System | 1 | 2005 | 251 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 821 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 1688 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2005 | 259 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2004 | 359 | 0.010 |
Why?
|
Mice | 1 | 2017 | 17622 | 0.010 |
Why?
|
Median Nerve | 1 | 1999 | 16 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1999 | 321 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 317 | 0.010 |
Why?
|